Emilia Hollingshed, 1, courageously fights a rare form of germ cell cancer, inspiring her family with every step of her ...
Natera’s fair value estimate has been raised to $202.50 from $193.80, reflecting renewed confidence in the company’s growth trajectory. The price target increase highlights optimism about Natera’s ...
Cancer has become a serious problem in today's life, involving more than 200 types. Know how small changes and symptoms can ...
As a result of a domestic research team reclassifying the diagnosis of pediatric malignant brain tumors according to the ...
ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced a lineup of presentations at the European Society for Medical Oncology (ESMO) Congre ...
A major risk factor for testicular cancer is an undescended testicle. In normal development, the testes fall or descend from ...
Natera Inc. (NASDAQ: NTRA) is one of the best growth stocks to buy now. On September 30, Natera announced the publication of ...
The platinum-resistant ovarian cancer market is expanding due to a growing unmet need, as many patients relapse after first-line platinum therapies, driving demand for novel second- and later-line ...
By Bill Gourgey Published Oct 4, 2025 12:00 PM EDT Image: Popular Science Composite Get the Popular Science daily newsletter💡 Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of ...
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. T-cell activation is essential for effective ...
Although pediatric cancer is rare, it is the leading cause of death by disease in children, according to the National Institutes of Health (NIH). Over 16,000 children in the United States are ...
Histologic Subvariants of Retroperitoneal Well-Differentiated Liposarcoma Show Evidence of Clinical and Genomic Progression Toward Dedifferentiated Liposarcoma Serum tumor markers (STMs), including ...